Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

How much tadalafil pre workout is a question increasingly asked online, yet tadalafil—a prescription-only phosphodiesterase type 5 (PDE5) inhibitor—is not licensed or clinically indicated for exercise performance enhancement in the UK. Approved by the MHRA solely for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension, tadalafil works by dilating blood vessels throughout the body. Using it as a pre-workout supplement is off-label, unsupported by robust evidence, and carries significant cardiovascular and safety risks. This article examines tadalafil's mechanism, the dangers of off-label use, and evidence-based alternatives for those seeking legitimate exercise performance improvements under medical guidance.
Summary: There is no clinically recommended dose of tadalafil for pre-workout use because it is not licensed or approved for exercise performance enhancement in the UK.
Tadalafil is a prescription-only medicine licensed in the UK for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which work by blocking the enzyme PDE5. This action increases levels of cyclic guanosine monophosphate (cGMP) in smooth muscle cells, leading to vasodilation—the widening of blood vessels.
In clinical practice, tadalafil is primarily prescribed to improve blood flow to the penis in men with ED, facilitating erections in response to sexual stimulation. The drug is also used to treat pulmonary arterial hypertension under the brand name Adcirca, where its vasodilatory effects help reduce blood pressure in the lungs. This PAH indication is specialist-initiated and follows different dosing protocols. Tadalafil has a notably long half-life of approximately 17.5 hours, meaning it remains active in the body for an extended period compared to other PDE5 inhibitors.
There is no official link or licensed indication for tadalafil as a pre-workout supplement or performance-enhancing agent. Some individuals have explored its off-label use based on the hypothesis that increased blood flow might enhance muscle pump, endurance, or oxygen delivery during exercise. However, this use is not supported by robust clinical evidence, and tadalafil is not approved by the MHRA or recommended by NICE for athletic or exercise performance enhancement.
The mechanism of action—vasodilation through PDE5 inhibition—affects vascular smooth muscle throughout the body, not selectively in skeletal muscle. This systemic effect raises important safety considerations when the drug is used outside its licensed indications, particularly in physically demanding contexts such as intense exercise.
Using tadalafil as a pre-workout supplement carries significant safety risks, particularly because it is being used outside its licensed indication and without appropriate medical supervision. Common adverse effects of tadalafil include headache, flushing, dyspepsia (indigestion), nasal congestion, back pain, and myalgia (muscle pain). These side effects may be exacerbated during strenuous physical activity and could impair exercise performance rather than enhance it.
More serious cardiovascular risks must be considered. Tadalafil causes vasodilation and can lower blood pressure, which may lead to dizziness, lightheadedness, or syncope (fainting), especially during intense exertion when blood pressure naturally fluctuates. Individuals with underlying cardiovascular conditions—including coronary artery disease, heart failure, arrhythmias, recent myocardial infarction or stroke—face heightened risks. The combination of tadalafil with nitrates (used for angina) or riociguat (a soluble guanylate cyclase stimulator) is absolutely contraindicated due to the risk of severe, potentially life-threatening hypotension.
Caution is needed when using tadalafil with alpha-blockers, as this combination may cause additive blood pressure-lowering effects. If prescribed for BPH, the combination is generally not recommended unless under careful medical supervision with stable doses of both medications.
Important interactions also exist with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir), which can increase tadalafil exposure, and CYP3A4 inducers (e.g., rifampicin), which can reduce its effectiveness. Alcohol and grapefruit juice may potentiate hypotensive effects and should be limited. There is also concern regarding interaction with stimulant-containing pre-workout supplements or energy drinks, which may produce unpredictable cardiovascular effects.
Patient safety advice:
Never use tadalafil without a prescription or medical assessment
Avoid combining tadalafil with nitrates, riociguat, or recreational drugs (particularly 'poppers')
Seek immediate medical attention if you experience chest pain (call 999), severe dizziness, prolonged erection lasting more than 4 hours (priapism), or sudden vision or hearing loss
Contact your GP before using tadalafil if you have cardiovascular disease, liver or kidney impairment, or take other regular medications
The MHRA emphasises that obtaining prescription-only medicines without proper medical oversight is both illegal and dangerous. Suspected side effects should be reported via the MHRA Yellow Card Scheme.
For individuals seeking to enhance exercise performance, there are numerous evidence-based, safer alternatives that do not carry the risks associated with off-label tadalafil use. Dietary nitrates, found naturally in beetroot juice and leafy green vegetables, have been shown in clinical studies to improve exercise endurance and reduce oxygen cost during physical activity. These work by increasing nitric oxide availability, promoting vasodilation through a different pathway than PDE5 inhibitors.
Caffeine is one of the most well-researched ergogenic aids, with robust evidence supporting its ability to enhance endurance, strength, and cognitive function during exercise. Typical effective doses range from 3–6 mg per kilogram of body weight, consumed 30–60 minutes before activity. For safety, most adults should limit intake to 400 mg daily (less during pregnancy or for those with certain health conditions such as anxiety disorders or cardiac arrhythmias). Caffeine is widely available, legal, and generally safe for most individuals when used appropriately.
Creatine monohydrate is another extensively studied supplement with strong evidence for improving high-intensity, short-duration exercise performance and supporting muscle mass gains. While NICE does not specifically endorse sports supplements, creatine has an established safety profile when used at recommended doses (typically 3–5 grams daily after a loading phase).
Other approaches with varying levels of evidence include:
Beta-alanine for buffering muscle acidity during high-intensity exercise (may cause harmless tingling sensations/paraesthesia)
Citrulline malate, which has some evidence for potential improvements in exercise performance and reduced muscle soreness, though research is less conclusive
Structured training programmes designed by qualified professionals
Adequate hydration, sleep, and nutrition—foundational elements often overlooked
Before starting any supplement regimen, individuals should consult with a GP, sports medicine physician, or registered dietitian, particularly if they have underlying health conditions or take regular medications. The UK Anti-Doping agency (UKAD) provides guidance on supplement safety for competitive athletes, including advice on using Informed Sport-certified products to reduce contamination risks.
Licensed clinical dosing for tadalafil in the UK varies according to indication. For erectile dysfunction, the typical on-demand dose is 10 mg taken prior to anticipated sexual activity (not more than once daily), which may be increased to 20 mg or decreased to 5 mg based on efficacy and tolerability. Alternatively, a daily dose of 2.5–5 mg may be prescribed for continuous treatment. For benign prostatic hyperplasia, the standard dose is 5 mg once daily. For pulmonary arterial hypertension, under specialist supervision, the dose is 40 mg once daily. These doses are established through rigorous clinical trials and approved by the MHRA.
In contrast, there are no evidence-based dosing guidelines for tadalafil as a pre-workout supplement because this is not a licensed or clinically studied indication. Anecdotal reports on internet forums suggest individuals may use doses ranging from 5–20 mg before exercise, but these practices lack scientific validation and medical oversight. Such use constitutes off-label prescribing if obtained through legitimate channels, or illegal acquisition if sourced without prescription.
The long half-life of tadalafil means that taking it daily or frequently (as might occur with regular pre-workout use) leads to drug accumulation in the body, increasing the risk of adverse effects. Timing considerations are also important: tadalafil reaches peak plasma concentrations approximately 2 hours after oral administration, though this varies between individuals. Unlike some medications, tadalafil absorption is not significantly affected by food.
Dose adjustments are required for patients with renal or hepatic impairment. Tadalafil is not recommended in severe renal impairment and is contraindicated in severe hepatic impairment.
Key clinical points:
Tadalafil should only be used under medical supervision for licensed indications
Self-medicating with tadalafil for exercise performance has no supporting clinical evidence
Obtaining tadalafil without prescription from unregulated online sources risks receiving counterfeit or contaminated products
If you are considering tadalafil for any reason, consult your GP for a proper assessment, discussion of risks and benefits, and exploration of appropriate, evidence-based alternatives. The NHS provides comprehensive guidance on safe medicine use and performance enhancement through its website and local services.
No, tadalafil is not licensed for pre-workout use and carries significant cardiovascular risks during exercise, including hypotension, dizziness, and dangerous interactions with other substances. It should only be used under medical supervision for approved indications.
Evidence-based alternatives include dietary nitrates from beetroot juice, caffeine at 3–6 mg per kilogram body weight, and creatine monohydrate at 3–5 grams daily. These have established safety profiles and proven performance benefits when used appropriately.
No, tadalafil is a prescription-only medicine in the UK and obtaining it without proper medical assessment is illegal. Using it for exercise performance is off-label and not supported by MHRA approval or NICE guidance.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript